Medicaid

McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services

IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)...

McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services

IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)...

Manifest MedEx Launches the California ADT Network, a Free Acute and Post-Acute Event Notification Exchange for California

The statewide nonprofit health information organization will send and receive Admit, Discharge, and Transfer (ADT) notifications at no cost for...

Manifest MedEx Launches the California ADT Network, a Free Acute and Post-Acute Event Notification Exchange for California

The statewide nonprofit health information organization will send and receive Admit, Discharge, and Transfer (ADT) notifications at no cost for...

Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services

WEST CHESTER, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology...

Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE)

Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE) Approval...

Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)

Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared...

New Study Published in Nature Scientific Reports Shows Industry-Leading Performance for Waymark Signal in Predicting Avoidable ER and Hospital Utilization

Peer-reviewed study demonstrates Waymark Signal is 90 percent accurate in predicting avoidable ER and hospital visitsSAN FRANCISCO, CA / ACCESSWIRE...

error: Content is protected !!